XML 22 R6.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Cash Flows - USD ($)
 9 Months Ended 12 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Dec. 31, 2020
Dec. 31, 2019
Cash flows from operating activities:        
Net (loss) income $ (903,866) $ (3,924,121) $ (6,261,398) $ 772,934
Adjustments to reconcile net (loss) income to net cash provided by operating activities:        
Depreciation and amortization 4,104,018 4,823,673 6,274,321 7,364,688
Stock compensation 867,903 541,865 1,105,272 686,133
Bad debt expense (recoveries) 52 93,958 77,898 (32,544)
Gain on sale of real estate assets, net (2,060,336) (656,975) (1,245,460) (6,319,272)
Gain on extinguishment of government debt (10,000) (451,785)
Net change in fair value marketable securities 37,673    
Impairment of real estate assets 300,000 845,674 1,730,851
Accretion of original issue discount 1,013,405 1,013,405 386,595
Amortization of financing costs 431,806 992,705 1,287,430 965,239
Amortization of above-market leases 42,064 38,012 50,682 55,466
Amortization of below-market leases (46,481) (122,439) (170,887) (185,995)
Straight-line rent adjustment (215,655) 67,732 108,998 (63,895)
Changes in operating assets and liabilities:        
Other assets 633,354 2,171,813 (1,957,641) (1,035,806)
Accounts payable and accrued liabilities (1,014,848) (1,974,401) (1,796,421) (767,440)
Accrued real estate taxes (1,040,680) (1,014,760) (438,915) (106,779)
Net cash provided by operating activities 1,125,004 2,896,141 3,693,417 3,790,936
Cash flows from investing activities:        
Real estate acquisitions (7,758,066) (8,996,248) (10,161,613) (13,037,562)
Additions to buildings and tenant improvements (1,122,051) (2,510,152) (2,834,373) (6,393,711)
Investment in marketable securities (2,682,192)    
Proceeds from sale of marketable securities 1,032,297    
Additions to deferred leasing costs (97,932) (137,961) (175,828) (661,401)
Proceeds from sales of real estate, net 47,906,909 33,810,274 40,849,654 32,073,721
Net cash provided by investing activities 37,278,965 22,165,913 27,677,840 11,981,047
Cash flows from financing activities:        
Proceeds from mortgage notes payable, net of issuance costs 8,003,807 13,339,739 14,152,838 15,494,715
Proceeds from government debt relief     45,178,500,000
Repayment of mortgage notes payable (41,862,782) (32,399,522) 36,808,331 23,176,581
Proceeds from note payable, net of issuance cost of $1.1 million     11,479,237
Repayment of note payable (7,675,598) (5,224,402) (6,324,401)
Payment of extension costs, note payable (351,025) (351,025)
Redemption of mandatorily redeemable preferred stock     (16,900,000)
Payment of deferred offering costs (572,458) (435,736) (45,016)
(Distributions) contributions to noncontrolling interests, net (5,624,969) (358,357) (2,366,009) 331,603
Issuance of stock for Initial Public Offering, net of underwriters fees 8,871,879 205,000,000,000
Issuance of Preferred Stock Series D, net of offering costs 20,489,803    
Repurchase of common stock (68,396) (18,000) (18,000) (227,428)
Dividends paid to preferred stockholders (455,207)    
Dividends paid to stockholders (3,234,669) (963,456) (2,158,469)
Net cash used in financing activities (22,128,590) (25,447,303) (30,221,615) (15,156,923)
Net increase in cash equivalents and restricted cash 16,275,379 (385,249) 1,149,642 615,060
Cash, cash equivalents and restricted cash - beginning of period 11,540,917 10,391,275 10,391,275 9,776,215
Cash, cash equivalents and restricted cash - end of period 27,816,296 10,006,026 11,540,917 10,391,275
Supplemental disclosure of cash flow information:        
Interest paid-Series B preferred stock     1,859,672
Interest paid-mortgage notes payable 3,407,689 4,542,959 5,892,025 6,442,750
Interest paid-notes payable 103,861 604,679 778,414 713,262
Non-cash financing activities:        
Issuance of stock for limited partnership interests 1,247,990 1,247,990
Dividends payable - Preferred Stock Series D $ 179,685    
Unpaid deferred financing costs     $ 83,659